Back to top
more

iShares U.S. Healthcare ETF: (IYH)

(Delayed Data from NYSE) As of Nov 3, 2026 03:59 PM ET

$77.22 USD

77.22
2,103,277

-0.38 (-0.49%)

Volume: 2,103,277

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $77.32 +0.10 (0.13 %) 7:58 PM ET

Zacks News

Sweta Killa headshot

Healthcare ETFs in Focus on UnitedHealth's Q4 Earnings

UnitedHealth Group reported mixed fourth-quarter 2019 results wherein it breezed past the Zacks Consensus Estimate on earnings but lagged on revenues.

Sanghamitra Saha headshot

Deal or No Deal: Healthcare ETFs to Make a Sweep in 2020

While all eyes are on the fate of the phase one trade deal between the United States and China, Healthcare sector can forget tension and soar higher in 2020 even if there is no deal.

Sweta Killa headshot

What's in Store for Healthcare ETFs in Q3 Earnings?

With earnings surprise in the cards, the healthcare sector is expected to witness modest earnings growth of 0.3% in the third quarter, suggesting some room for potential upside for healthcare ETFs.

Sweta Killa headshot

Healthcare ETFs to Buy on UnitedHealth's Solid Q3 Earnings

Investors could tap the company's strong growth story with ETFs having the largest allocation to this health insurance giant.

Sweta Killa headshot

JNJ Beats, Ups View: Healthcare ETFs to Buy

Johnson & Johnson continued its long streak of earnings beat and outpaced revenue estimates. It also raised its guidance for the full year.

Sweta Killa headshot

Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy

With earnings surprise in cards, the healthcare sector is expected to witness earnings growth of 1.7% in the second quarter, suggesting continued outperformance for healthcare ETFs.

Sweta Killa headshot

Healthcare ETFs in Focus on UnitedHealth's Q2 Earnings

ETFs having the largest allocation to this health insurance giant are in focus post Q2 earnings.

Sweta Killa headshot

Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat

Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.

Sweta Killa headshot

Forget Trade Fears, Invest in Defensive Sector ETFs

Investors are seeking to beat the fresh tariff woes by betting on defensive sectors like utilities, real estate, healthcare and consumer staples. We have highlighted one ETF each from these four zones.

Sweta Killa headshot

Can Q1 Earnings Lift Healthcare ETFs Higher?

With negative earnings revisions, the healthcare sector is expected to witness earnings growth of 1.8% in the first quarter, suggesting smooth trading for healthcare ETFs.